WO2023226987 - GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES
National phase entry is expected:
Publication Number
WO/2023/226987
Publication Date
30.11.2023
International Application No.
PCT/CN2023/095823
International Filing Date
23.05.2023
Title **
[English]
GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES
[French]
ANIMAL NON HUMAIN GÉNÉTIQUEMENT MODIFIÉ COMPORTANT DES GÈNES HUMAINS OU CHIMÉRIQUES
Applicants **
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Inventors
SHANG, Chengzhang
WANG, Linlin
ZHAO, Suman
YUAN, Jiangfeng
Priority Data
202210565505.7
23.05.2022
CN
202211214520.3
30.09.2022
CN
202211364219.0
02.11.2022
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5304 | |
| EPO | Filing, Examination, Granting | 86490 | |
| Japan | Filing, Examination, Granting | 4720 | |
| South Korea | Filing, Examination, Granting | 7599 | |
| USA | Filing, Examination, Granting | 31840 |
Total:
135,953
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) IL2RG, IL2RB, IL15RA, and/or IL15, and methods of use thereof.[French]
La présente divulgation concerne des animaux non humains génétiquement modifiés exprimant une IL2RG, une IL2RB, une IL15RA et/ou une IL15 humaine ou chimérique (p. ex. humanisée), ainsi que leurs procédés d'utilisation.